These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25092043)

  • 21. A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy.
    Murata M; Furusyo N; Ogawa E; Mitsumoto F; Hiramine S; Ikezaki H; Takayama K; Shimizu M; Toyoda K; Kainuma M; Hayashi J
    J Infect Chemother; 2014 May; 20(5):320-4. PubMed ID: 24477330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus infection is associated with endothelial dysfunction in HIV/hepatitis C virus coinfected patients.
    de Castro IF; Micheloud D; Berenguer J; Guzmán-Fulgencio M; Catalán P; Miralles P; Alvarez E; López JC; Cosín J; Lorente R; Muñoz-Fernández MA; Resino S
    AIDS; 2010 Aug; 24(13):2059-67. PubMed ID: 20616694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus recover genotype cross-reactive neutralising antibodies to HCV during antiretroviral therapy.
    Lee S; Saraswati H; Yunihastuti E; Gani R; Price P
    Clin Immunol; 2014 Dec; 155(2):149-59. PubMed ID: 25283333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
    Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
    Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management issues in patients coinfected with hepatitis C virus and HIV.
    Bonacini M
    AIDS Read; 2002 Jan; 12(1):19-21, 24-6. PubMed ID: 11862656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing treatment in HIV/HCV coinfection.
    Puoti M; Rossotti R; Travi G; Panzeri C; Morreale M; Chiari E; Cocca G; Orso M; Moioli MC
    Dig Liver Dis; 2013 Sep; 45 Suppl 5():S355-62. PubMed ID: 24091116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.
    Sanmartín R; Tor J; Sanvisens A; López JJ; Jou A; Muga R; Ojanguren I; Barluenga E; Videla S; Planas R; Clotet B; Tural C
    HIV Med; 2014 Apr; 15(4):203-12. PubMed ID: 24245909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver failure in human immunodeficiency virus - Hepatitis C virus coinfection treated with sofosbuvir, ledipasvir and antiretroviral therapy.
    Marchan-Lopez A; Dominguez-Dominguez L; Kessler-Saiz P; Jarrin-Estupiñan ME
    J Hepatol; 2016 Mar; 64(3):752-3. PubMed ID: 26682727
    [No Abstract]   [Full Text] [Related]  

  • 29. New paradigms in the management of hepatitis C virus co-infections.
    Sherman KE
    Nat Clin Pract Gastroenterol Hepatol; 2007 Jan; 4 Suppl 1():S10-6. PubMed ID: 17235280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV/hepatitis C virus coinfection management: changing guidelines and changing paradigms.
    Cooper CL; Klein MB
    HIV Med; 2014 Nov; 15(10):621-4. PubMed ID: 24802099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of hepatitis C in patients infected with human immunodeficiency virus in the direct-acting antiviral era.
    Soriano V; Labarga P; Vispo E; Fernández-Montero JV; Barreiro P
    Infect Dis Clin North Am; 2012 Dec; 26(4):931-48. PubMed ID: 23083825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preemptive antiretroviral therapy modifications for the management of potential clinically significant drug interactions with direct acting hepatitis C therapies.
    Stambough M; Roman M; Blair DC; Sidman EF; Miller CD
    Int J STD AIDS; 2016 Mar; 27(3):235-7. PubMed ID: 25824150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C and human immunodeficiency virus coinfection in the era of direct-acting antiviral agents: No longer a difficult-to-treat population.
    Sikavi C; Chen PH; Lee AD; Saab EG; Choi G; Saab S
    Hepatology; 2018 Mar; 67(3):847-857. PubMed ID: 29108121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV and hepatitis C co-infection: the role of HAART in HIV/hepatitis C virus management.
    Jones M; Núñez M
    Curr Opin HIV AIDS; 2011 Nov; 6(6):546-52. PubMed ID: 22001896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perspectives on HCV: Current Therapeutic Regimens and Drug-Drug Interactions.
    Chan J; Chung RT
    Clin Pharmacol Drug Dev; 2017 Mar; 6(2):147-163. PubMed ID: 28263458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of hepatitis C virus and HIV coinfection: the road less traveled.
    Jones JS; Dieterich DT
    AIDS Read; 2001 Oct; 11(10):505-10; quiz 529-30. PubMed ID: 11708083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfection.
    Schulze Zur Wiesch J; Pieper D; Stahmer I; Eiermann T; Buggisch P; Lohse A; Hauber J; van Lunzen J
    Clin Infect Dis; 2009 Aug; 49(3):466-72. PubMed ID: 19580412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peginterferon alfa-2a plus ribavirin for HIV-HCV genotype 1 coinfected patients: a randomized international trial.
    Rodriguez-Torres M; Slim J; Bhatti L; Sterling R; Sulkowski M; Hassanein T; Serrão R; Sola R; Bertasso A; Passe And S; Stancic S
    HIV Clin Trials; 2012; 13(3):142-52. PubMed ID: 22592094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of acute and chronic HCV infection in persons with HIV coinfection.
    Sulkowski MS
    J Hepatol; 2014 Nov; 61(1 Suppl):S108-19. PubMed ID: 25443339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of human immunodeficiency virus coinfection on the progression of mother-to-child transmitted hepatitis C virus infection.
    Claret-Teruel G; Noguera-Julian A; Esteva C; Muñoz-Almagro C; Sánchez E; Jiménez R; Fortuny C
    Pediatr Infect Dis J; 2011 Sep; 30(9):801-4. PubMed ID: 21772231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.